Wave life sciences reports fourth quarter and full year 2022 financial results and provides business update

Achieved clinical validation of prism platform in 2022 – demonstrated ability to potently and durably engage rna targets and translate preclinical data to the clinic

WVE Ratings Summary

WVE Quant Ranking